Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa–dependent manner

G Ahlenstiel, RH Titerence, C Koh, B Edlich, JJ Feld… - Gastroenterology, 2010 - Elsevier
BACKGROUND & AIMS: Patients with chronic hepatitis C virus (HCV) infection display great
variability in disease activity and progression. Although virus-specific adaptive immune …

Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C

G Ahlenstiel, B Edlich, LJ Hogdal, Y Rotman… - Gastroenterology, 2011 - Elsevier
BACKGROUND & AIMS: Mathematical modeling of hepatitis C virus (HCV) kinetics indicated
that cellular immune responses contribute to interferon (IFN)-induced clearance of HCV. …

[PDF][PDF] Early changes in interferon signaling define natural killer cell response and refractoriness to interferon‐based therapy of hepatitis C patients

B Edlich, G Ahlenstiel, AA Zabaleta, J Stoltzfus… - …, 2012 - Wiley Online Library
Natural killer (NK) cells exhibit a polarized phenotype with increased cytotoxicity and decreased
interferon gamma (IFN‐γ) production in chronic hepatitis C virus (HCV) infection. Here, …

Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C

…, N Gara, S Sarkar, E Thomas, G Ahlenstiel, B Edlich… - Gut, 2014 - gut.bmj.com
Objective Ribavirin improves treatment response to pegylated-interferon (PEG-IFN) in chronic
hepatitis C but the mechanism remains controversial. We studied correlates of response …

Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine–a Phase I trial

…, A Rittmeyer, A Borgmeier, P Ferré, B Edlich… - OncoTargets and …, 2017 - Taylor & Francis
Micro-abstract In a Phase I dose-finding study of metronomic daily oral vinorelbine in advanced
non-small-cell lung cancer, a recommended dose was established for this therapeutic …

Vinflunine in the treatment of upper tract Urothelial carcinoma–subgroup analysis of an observational study

…, PJ Goebell, U Matz, W De Schultz, B Edlich… - Anticancer …, 2017 - ar.iiarjournals.org
Background/Aim: Despite an expected prognostic disadvantage for upper tract versus lower
tract metastatic urothelial carcinomas (UTUC/LTUC), only few studies have been conducted …

Dendritic cells transfected with Her2 antigen-encoding RNA replicons cross-prime CD8 T cells and protect mice against tumor challenge

B Edlich, LJ Hogdal, B Rehermann, SE Behrens - Vaccine, 2010 - Elsevier
Antigen-specific T cells can be induced by direct priming and cross-priming. To investigate
cross-priming as a vaccination approach dendritic cells were transfected with cytopathogenic …

GILT–Eine randomisierte Phase-III-Studie mit oralem Vinorelbin und Cisplatin plus konkomitanter Strahlentherapie gefolgt von konsolidierender Therapie mit oralem …

…, N Vaissiere, C De Almeida, B Edlich… - Strahlentherapie und …, 2016 - Springer
GILT—A randomised phase III study of oral vinorelbine and cisplatin with concomitant
radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best …

Response to vinflunine treatment after prior platinum-based chemotherapy in patients with advanced urothelial carcinoma independent of primary tumor location.

…, PJ Goebell, U Matz, W de Schultz, B Edlich… - 2015 - ascopubs.org
e15536 Background: The outcome of chemotherapy in patients with metastatic urothelial
carcinoma (UC) of the upper tract (UT) is generally assumed to be worse compared to bladder …

[PDF][PDF] Dendritic cells transfected with Her2-encoding RNA replicons induce cross-priming and protect mice against tumor challenge

B Edlich - 2010 - opendata.uni-halle.de
1 Summary Cancer is a leading cause of death worldwide. Despite the improvement of
conventional cancer therapies, the mortality rate remains high and current treatment options are …